has received consulting fees on behalf of Newcastle University from 89bio, Akero, Alimentiv, AstraZeneca, Axcella, Boehringer Ingelheim, Bristol Myers Squibb, Galmed, Genentech, Genfit, Gilead, GlaxoSmithKline, Hanmi, HistoIndex, Intercept, Inventiva, Ionis, IQVIA, Janssen, Madrigal, Medpace, Merck, NGMBio, Novartis, Novo Nordisk, PathAI, Pfizer, Pharmanest, Poxel, Prosciento, Resolution Therapeutics, Ridgeline Therapeutics, Roche, RTI, Shionogi and Terns Pharmaceuticals
MT-1 was originally developed as a potential therapeutic agent for conditions like erythropoietic protoporphyria (EPP) and other photosensitivity disorders, where increased melanin production could reduce UV-induced damage
These processes are considered important for connective tissue repair
By addressing how much coffee you consume and its potential effects on both your health and medication results, together you can develop an optimized treatment plan